Dr. Prasad studies the quality of medical evidence, cancer drug development, clinical trial design, and health care policy. His work utilizes a wide range of epidemiological methods, and falls …

Apr 21, 2018 · Dr. Prasad is available for speaking events. Prior lectures include cancer drugs, cost of medical care, health policy, evidence based medicine, the politics of science and …

Dr. Vinay Prasad, an Assistant Professor of Medicine from the Oregon Health and Science University, in Portland, in his article appearing in the December 2015 issue of Mayo Clinic …

ContactContact You may contact me via email through the form below. Please include your email and phone number

In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced.

Prasad V, Kaestner V. Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable. Seminars in Oncology. 2017.

Vinay Prasad reviews Jeanne Lenzer’s book on the medical device industry. BMJ 2019. 2018 Prasad on Medicine. Medscape. When Do We Need Randomized Controlled Trials, and When …

Plenary Session - inactive due to federal service - Trump is breaking media brains / NIH cuts indirect payments and scientists freak out